Big Health Care Companies Are Undervalued
McKesson and Walgreens are strong, healthy companies, despite recent downturns in their stock prices, a CEO in the investment field says.
Rite Aid Execs Depart in Sweeping Restructuring
The company is slashing about 400 corporate positions, and its CEO, CFO, and COO will exit as part of a leadership revamp.
Why Amazon’s Stock Isn’t as Great as You Think
For CFOs wanting to understand investor behavior, here's an argument that Jeff Bezos is human, after all, and Amazon can't defy basic economic principles.
CFOs on the Move: Week Ending March 9
Univision, Walgreens, UGI, Lubrizol, Sequential Brands, Infoblox, Maxar Technologies, West Pharmaceutical Services, FormFactor, Career Education
What Wildfires, Hurricanes Can Teach About Risk Reduction
Companies can leverage their involvement in infrastructure development to raise resiliency standards.
Walgreens Scraps Rite Aid Merger
Under a scaled-down deal, Walgreens would buy roughly half of Rite Aid’s stores.
Walgreens to Pay $2 Billion Less for Rite Aid
The amended terms of the megamerger reflect the companies' efforts to obtain regulatory approval.
Valeant to Take $150M Hit From Walgreens Deal
Valeant's revenue hit will include the value of the drugs shifted to consignment status and expected delays recognizing revenue from the Walgreens deal.
Finance and Accounting Roundup for Executives
Be informed, get involved, and shape the world through finance. Here's today's CFO roundup.
Walgreens Buys Rite Aid for $9.4 Billion
The combination of two of the three largest U.S. drug store chains continues a wave of industry consolidation spurred by the Affordable Care Act.
After Merger, Walgreens Plans $1.5B in Cost Cuts
The focus is on operations for the newly global company, which will close 200 U.S. stores.